Autoantibodies to N-terminally truncated GAD (t-GADA) comprising amino acids 96-585 have been reported to identify more specifically at-risk relatives of patients with T1D than autoantibodies to full-length GAD (f-GADA) (2). The gene discussed is GAD1; the disease is type 1 diabetes mellitus.